APOE ɛ4-carriers with stroke had lower cognitive function in both cognitive domains, which is in agreement with the previously found synergistic effect of having both AD pathology (accelerated by ɛ4-carriership) and cerebrovascular disease [50–53]. This evidence concerns the gene APOE and Stroke.